Comparing high and low total body irradiation dose rates for minimum-intensity conditioning of dogs for dog leukocyte antigen-identical bone marrow grafts

Biology of Blood and Marrow Transplantation

Volumn 19, Issue 11, 2013, Pages 1650-1654

  Graves, Scott S ^a,b   Storer, Barry E ^a,b   Butts, Tiffany M ^a   Storb, Rainer ^a,b  

^a USA   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Dog; Dose rate; Hematopoietic cell transplantation; Mixed chimerism; Nonmyeloablative conditioning regimen

Indexed keywords

CYCLOSPORIN; LEUKOCYTE ANTIGEN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;

ARTICLE; BONE MARROW TRANSPLANTATION; CHIMERA; CONDITIONING; CONTROLLED STUDY; DOG; GRAFT REJECTION; IMMUNOSUPPRESSIVE TREATMENT; NONHUMAN; RADIATION DOSE; WHOLE BODY RADIATION;

DOG; DOSE RATE; HEMATOPOIETIC CELL TRANSPLANTATION; MIXED CHIMERISM; NONMYELOABLATIVE CONDITIONING REGIMEN;

ANIMALS; BONE MARROW TRANSPLANTATION; DOGS; DOSE-RESPONSE RELATIONSHIP, RADIATION; GRAFT SURVIVAL; TRANSPLANTATION CHIMERA; TRANSPLANTATION CONDITIONING; TRANSPLANTATION, HOMOLOGOUS; WHOLE-BODY IRRADIATION;

EID: 84885711412     PISSN: 10838791     EISSN: 15236536     Source Type: Journal    
DOI: 10.1016/j.bbmt.2013.08.007     Document Type: Article

References (18)

1. Storb R., Yu C., Wagner J.L., et al. Stable mixed hematopoietic chimerism in DLA-identical littermate dogs given sublethal total body irradiation before and pharmacological immunosuppression after marrow transplantation. Blood 1997, 89:3048-3054.
2. Hogan W.J., Little M.-T., Zellmer E., et al. Postgrafting immunosuppression with sirolimus and cyclosporine facilitates stable mixed hematopoietic chimerism in dogs given sublethal total body irradiation before marrow transplantation from DLA-identical littermates. Biol Blood Marrow Transplant 2003, 9:489-495.
3. Storb R., Yu C., Barnett T., et al. Stable mixed hematopoietic chimerism in dog leukocyte antigen-identical littermate dogs given lymph node irradiation before and pharmacologic immunosuppression after marrow transplantation. Blood 1999, 94:1131-1136.
4. Storb R.F., Champlin R., Riddell S.R., et al. Non-myeloablative transplants for malignant disease. Hematology 2001: American Society of Hematology Education Program Book 2001, 375-391. American Society of Hematology, Washington, DC. G.P. Schechter, V.C. Broudy, M.E. Williams (Eds.).
5. Thakar M.S., Kurre P., Storb R., et al. Treatment of Fanconi anemia patients using fludarabine and low-dose TBI, followed by unrelated donor hematopoietic cell transplantation. Bone Marrow Transplant 2011, 46:539-544.
6. Sorror M.L., Leisenring W., Mielcarek M., et al. Intensified postgrafting immunosuppression failed to assure long-term engraftment of dog leukocyte antigen-identical canine marrow grafts after 1 gray total body irradiation. Transplantation 2008, 85:1023-1029.
7. Lee W.S., Suzuki Y., Graves S.S., et al. Canine bone marrow-derived mesenchymal stromal cells suppress alloreactive lymphocyte proliferation invitro but fail to enhance engraftment in canine bone marrow transplantation. Biol Blood Marrow Transplant 2011, 17:465-475.
8. Storb R., Yu C., Zaucha J.M., et al. Stable mixed hematopoietic chimerism in dogs given donor antigen, CTLA4Ig, and 100 cGy total body irradiation before and pharmacologic immunosuppression after marrow transplant. Blood 1999, 94:2523-2529.
9. Jochum C., Beste M., Zellmer E., et al. CD154 blockade and donor-specific transfusions in DLA-identical marrow transplantation in dogs conditioned with 1-Gy total body irradiation. Biol Blood Marrow Transplant 2007, 13:164-171.
10. Storb R., Raff R.F., Appelbaum F.R., et al. Fractionated versus single-dose total body irradiation at low and high dose rates to condition canine littermates for DLA-identical marrow grafts. Blood 1994, 83:3384-3389.
11. Wagner J.L., Burnett R.C., DeRose S.A., et al. Histocompatibility testing of dog families with highly polymorphic microsatellite markers. Transplantation 1996, 62:876-877.
12. Wagner J.L., Works J.D., Storb R. DLA-DRB1 and DLA-DQB1 histocompatibility typing by PCR-SSCP and sequencing. Tissue Antigens 1998, 52:397-401.
13. Yunusov M.Y., Georges G.E., Storb R., et al. FLT3 ligand promotes engraftment of allogeneic hematopoietic stem cells without significant graft-versus-host disease. Transplantation 2003, 75:933-940.
14. n polymorphisms to determine the origin of blood cells after allogeneic canine marrow grafting. Transplantation 1994, 58:701-706.
15. Hilgendorf I., Weirich V., Zeng L., et al. Canine haematopoietic chimerism analyses by semiquantitative fluorescence detection of variable number of tandem repeat polymorphism. Vet Res Commun 2005, 29:103-110.
16. Graves S.S., Hogan W., Kuhr C.S., et al. Stable trichimerism after marrow grafting from 2 DLA-identical canine donors and nonmyeloablative conditioning. Blood 2007, 110:418-423.
17. Storb R., Raff R.F., Graham T., et al. Dose rate-dependent marrow toxicity of TBI in dogs and marrow sparing effect at high dose rate by dose fractionation. Biol Blood Marrow Transplant 1999, 5:155-161.
18. Gengozian N., Carlson D.E., Allen E.M. Transplantation of allogeneic and xenogeneic (rat) marrow in irradiated mice as affected by radiation exposure rates. Transplantation 1969, 7:259-273.